Binaural Sound Effects for General Anesthesia
BS
The Effect of Preoperative Binaural Sound on Propofol Dose Required for Induction of General Anesthesia: a Randomized, Placebo-controlled Trial
1 other identifier
interventional
76
1 country
1
Brief Summary
30 minutes before entering the operating room, the anxiety score is evaluated using a visual analogue scale (VAS) score, and stereo headphones, which can transmit binaural beat, are put on. According to a computer-generated assignment table, subjects are divided into an experimental group and a control group. Binaural beat is applied to the experimental group for 20 minutes, and a silent state is applied to the control group for 20 minutes. After entering the operating room, electrocardiogram, pulse oxymetry, non-invasive blood pressure monitor, and sensor for depth of anesthsia are attached. Before induction of anesthesia, the anxiety score is evaluated on a VAS, again. For anesthesia induction, propofol is administered at a rate of 10 mg every 15 seconds over 5 seconds. Assess the amount of propofol administered until the response to voice ("Open your eyes.") is absent, the subject's eyelash reflex disappears, and the PSI reaches below 50. Discontinue propofol injection when all three assessments (unresponsiveness to voice, loss of eyelash reflexes, Patient Sate Index (PSI) ≤ 50) become positive.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 9, 2022
CompletedFirst Posted
Study publicly available on registry
June 24, 2022
CompletedStudy Start
First participant enrolled
July 5, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 7, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 7, 2023
CompletedAugust 15, 2023
August 1, 2023
1.2 years
June 9, 2022
August 11, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Propofol dose
The amount of propofol administered until the response to the voice ("Open your eyes.") becomes absent
Until the response to the voice ("Open your eyes.") becomes absent (up to 5minutes)
Secondary Outcomes (5)
Propofol dose
until eyelash reflex disappears (up to 5minutes)
Propofol dose
until PSI falls below 50 (up to 5minutes)
Anxiety
20minutes before the entrance to the operating room
Anxiety
just before induction of anesthesia
Brainwaves
From the time you enter the operation room until the anesthesia induction is complete (up to 30minutes)
Study Arms (2)
Control
PLACEBO COMPARATORA silent state (a wave file made without sound) is applied for at least 20 minutes from 20 minutes before arrival to the operating room. The sound generator is a smartphone device, set the volume (at a volume corresponding to 60 dB in the experimental group), and hang it on the transport bed. Upon arrival in the operating room, before anesthesia, the volume is adjusted to 0.
Binaural beat
EXPERIMENTALIn the experimental group, the binaural sound, which was produced by the beat of 2Hz difference, is applied for 20 minutes from 20 minutes before arrival to the operating room. The sound generator is a smartphone device, set the volume corresponding to 60 dB, and hang it on the transport bed. Upon arrival in the operating room, before anesthesia, the volume is adjusted to 0.
Interventions
Different frequencies are transmitted in both ears, causing beats. The low frequency sound generated by beats induces brainwaves entrainment.
Eligibility Criteria
You may qualify if:
- Adult patients aged 20-50 who require general anesthesia
- Patients who are able to provide written consent to participate in the clinical trial, to understand the procedure of this clinical trial, and to fill out the questionnaire appropriately
- Patients with ASA physical status classification 1-2
- Patients weighing from 50 kg to 80 kg
You may not qualify if:
- Patients with hearing loss or using hearing aids
- Patients who received narcotic analgesics or sedative drugs within 1 week
- Patients with alcohol or drug dependence
- Patients with drug hypersensitivity to propofol
- Patients with arrhythmia, cardiovascular disease, and decreased heart function
- Patients with liver failure
- Patients who are judged to be inappropriate for this clinical trial according to the opinions of investigators
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Seoul National University Hospital
Seoul, South Korea
Related Publications (5)
Schmid W, Marhofer P, Opfermann P, Zadrazil M, Kimberger O, Triffterer L, Marhofer D, Klug W. Brainwave entrainment to minimise sedative drug doses in paediatric surgery: a randomised controlled trial. Br J Anaesth. 2020 Sep;125(3):330-335. doi: 10.1016/j.bja.2020.05.050. Epub 2020 Jul 8.
PMID: 32653082BACKGROUNDTurkistani A, Abdullah KM, Al-Shaer AA, Mazen KF, Alkatheri K. Melatonin premedication and the induction dose of propofol. Eur J Anaesthesiol. 2007 May;24(5):399-402. doi: 10.1017/S0265021506001505. Epub 2006 Nov 10.
PMID: 17094871BACKGROUNDFacco E, Stellini E, Bacci C, Manani G, Pavan C, Cavallin F, Zanette G. Validation of visual analogue scale for anxiety (VAS-A) in preanesthesia evaluation. Minerva Anestesiol. 2013 Dec;79(12):1389-95. Epub 2013 Jul 9.
PMID: 23860442BACKGROUNDPadmanabhan R, Hildreth AJ, Laws D. A prospective, randomised, controlled study examining binaural beat audio and pre-operative anxiety in patients undergoing general anaesthesia for day case surgery. Anaesthesia. 2005 Sep;60(9):874-7. doi: 10.1111/j.1365-2044.2005.04287.x.
PMID: 16115248BACKGROUNDKim YJ, Choe HW, Yoon SB, Lee H, Kim HS, Seo JH. Effects of preoperative binaural beats on the propofol dose for induction of general anesthesia: a randomized controlled trial. Can J Anaesth. 2025 Jul;72(7):1101-1109. doi: 10.1007/s12630-025-02993-5. Epub 2025 Jun 25.
PMID: 40563070DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Jeong-Hwa Seo, MD.,PhD.
Seoul National University Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 9, 2022
First Posted
June 24, 2022
Study Start
July 5, 2022
Primary Completion
September 7, 2023
Study Completion
October 7, 2023
Last Updated
August 15, 2023
Record last verified: 2023-08